Skip to main content

Table 1 Summary of changes in clinical outcome measures for individuals with baseline and first follow-up assessment

From: ‘Work it out’: evaluation of a chronic condition self-management program for urban Aboriginal and Torres Strait Islander people, with or at risk of cardiovascular disease

Clinical Outcome Measure

n

Mean Change (95% CI)

Baseline Measurement (SD)

Follow-up Measurement (SD)

p-value†

Weight (kg)

65

−0.57 (−1.28, 0.14)

98.90 (27.97)

98.32 (27.65)

0.113

Weight within BMI Groups (kg)

Healthy

≤10

0.26 (−3.30, 3.82)

66.53 (7.84)

66.80 (8.13)

Overweight

≥10

−0.02 (−1.12, 1.08)

76.35 (9.76)

76.33 (10.40)

0.974

Obese I

15

−1.21 (−3.11, 0.69)

92.39 (12.37)

91.17 (11.11)

0.194

Obese II

12

0.85 (−0.46, 2.15)

95.64 (9.67)

96.48 (9.67)

0.181

Extreme Obesity

19

−1.57 (−3.03, −0.10)

130.55 (27.23)

128.98 (28.09)

0.037*

BMI (kg/m2)

64

−0.20 (−0.47, 0.07)

35.85 (8.92)

35.65 (8.80)

0.15

Systolic BP (mmHg)

58

−0.71 (−4.85, 3.43)

128.21 (16.84)

127.50 (16.31)

0.734

Systolic BP within BP Categories (mmHg)

Normal

≥10

8.19 (3.45, 12.93)

110.29 (6.41)

118.48 (10.06)

0.002*

High/Normal

≥10

−0.79 (−8.17, 6.59)

129.21 (4.88)

128.42 (14.82)

0.825

High

18

−11.00 (−18.82, −3.18)

148.06 (7.87)

137.06 (18.49)

0.009*

Diastolic BP (mmHg)

58

−0.12, (−3.49, 3.25)

80.50 (10.17)

80.38 (11.29)

0.943

Diastolic BP within BP Categories (mmHg)

Normal

≥10

5.31 (1.59, 9.04)

73.63 (6.65)

78.94 (9.55)

0.007*

High/Normal

≥10

−5.87 (−13.48, 1.74)

85.13 (2.87)

79.25 (13.88)

0.121

High

9

−8.11 (−16.08, −0.14)

93.33 (4.06)

85.22 (10.12)

Waist circumference (cm)

60

−0.58 (−3.06, 1.89)

116.32 (19.86)

115.73 (18.98)

0.63

Waist circumference within Waist circumference groups (cm)

No increased risk

≤10

5.33 (−5.01, 15.68)

93.66 (10.06)

88.33 (8.08)

Increased risk

≤10

1.77 (−14.15, 17.69)

84.07 (3.00)

85.83 (4.54)

Substantially increased risk

54

−1.05 (−3.74, 1.65)

119.7 (17.94)

118.62 (17.61)

0.44

Hip circumference (cm)

57

−0.65 (−2.55, 1.25)

123.57 (18.39)

122.9 (19.80)

0.49

WHR (waist/hip)

57

0.0007 (−0.024, 0.025)

0.94 (0.093)

0.95 (0.091)

0.95

WHR within WHR Groups (waist/hip)

No increased risk

≤10

0.108 (−0.001, 0.219)

0.81 (0.022)

0.92 (0.12)

Substantially increased risk

≥10

−0.016 (−0.038, 0.004)

0.97 (0.080)

0.95 (0.086)

0.12

6MWT (km)

47

0.053 (0.01, 0.07)

0.38 (0.18)

0.43 (0.16)

0.023*

  1. † Paired t-test used to compare baseline and follow-up measurement. Statistical testing only conducted when n > 10 in each group
  2. *Significant at p < 0.05